EXHIBIT 2.2Escrow Agreement • May 18th, 1999 • Geron Corporation • Pharmaceutical preparations • New York
1 EXHIBIT 4.3 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR...Warrant Agreement • September 27th, 2001 • Geron Corporation • Pharmaceutical preparations • California
EXHIBIT 4.1 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR...Warrant Agreement • October 30th, 2007 • Geron Corp • Pharmaceutical preparations • New York
RECITALSSecurities Purchase Agreement • May 15th, 2000 • Geron Corporation • Pharmaceutical preparations • California
EXHIBIT 1.1Underwriting Agreement • October 29th, 2003 • Geron Corporation • Pharmaceutical preparations • New York
EXHIBIT C TO SECURITIES PURCHASE AGREEMENT REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of June 29, 2000, by and between Geron Corporation, a Delaware corporation, with its headquarters located at 230...Registration Rights Agreement • July 6th, 2000 • Geron Corporation • Pharmaceutical preparations • Delaware
Right to Purchase _________ Shares of Common Stock, par value $0.001 per share COMMON STOCK PURCHASE WARRANT D THIS CERTIFIES THAT, for value received, _____________ or its registered assigns (the "Holder"), is entitled to purchase from Geron...Common Stock Purchase Warrant • March 1st, 2007 • Geron Corp • Pharmaceutical preparations • Delaware
GERON CORPORATION SECOND AMENDMENT TO NOTE SECURED BY STOCK PLEDGE AGREEMENTPromissory Note • May 13th, 1997 • Geron Corporation • Pharmaceutical preparations
Common Warrants to Purchase up to 35,714,286 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 30th, 2022 • Geron Corp • Pharmaceutical preparations • New York
Commission on Form 4 in accordance with Section 16(a) (“Section 16(a)”) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the Lock-Up Period, and (2) not apply to the exercise of any option, warrant or other right to acquire shares of Common Stock on a cash basis or the conversion of any convertible security into securities of the Company, provided that in any such case, the Common Stock issued upon such exercise, settlement or conversion shall remain subject to the provisions of this lock-up agreement.
1 EXHIBIT 1.1 GERON CORPORATION 3,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • April 7th, 2000 • Geron Corporation • Pharmaceutical preparations • New York
EXHIBIT 4.1 COMMON STOCK PURCHASE AGREEMENT THIS COMMON STOCK PURCHASE AGREEMENT ("Agreement") is made and entered into as of August 13, 2008 (the "Effective Date"), by and between GERON CORPORATION, a Delaware corporation having its principal place...Common Stock Purchase Agreement • August 21st, 2008 • Geron Corp • Pharmaceutical preparations • California
AMENDMENT NO. 1 SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 1st, 1999 • Geron Corporation • Pharmaceutical preparations • New York
ARTICLE I DEFINITIONSEmployment Agreement • April 30th, 2003 • Geron Corporation • Pharmaceutical preparations • California
GERON CORPORATION Issuer AND [TRUSTEE], Trustee _______________ INDENTURE Dated as of [●], 20__ Debt SecuritiesIndenture • May 24th, 2018 • Geron Corp • Pharmaceutical preparations • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
EXHBIT 10.1 FIFTH AMENDMENT TO LEASE THIS FIFTH AMENDMENT TO LEASE ("Fifth Amendment") is made this 19th day of March, 2008 (the "Effective Date"), between DAVID D. BOHANNON ORGANIZATION, a California corporation, herein referred to as "Landlord", and...Lease • April 30th, 2008 • Geron Corp • Pharmaceutical preparations • California
EXHIBIT 10.38 SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT (this "AGREEMENT"), dated as of March 27, 1998, by and among Geron Corporation, a Delaware corporation, with headquarters located at 230 Constitution Drive, Menlo Park,...Securities Purchase Agreement • April 2nd, 1998 • Geron Corporation • Pharmaceutical preparations • Delaware
EXHIBIT 10.2 DATED 15th June 2007 (1) BIOTECHNOLOGY RESEARCH CORPORATION LIMITED (2) GERON CORPORATION (3) TA THERAPEUTICS LIMITED AMENDED AND RESTATED JOINT VENTURE AGREEMENT ----------------------------------------------------------Joint Venture Agreement • July 31st, 2007 • Geron Corp • Pharmaceutical preparations • Hong Kong
April 22, 2005 Geron Corporation 230 Constitution Drive Menlo Park, California 94025 Attention: Chief Financial Officer Ladies and Gentlemen: Geron Corporation, a Delaware corporation, (the "Company"), and certain investors including the undersigned,...Lock-Up Agreement • April 25th, 2005 • Geron Corporation • Pharmaceutical preparations • California
Geron Corporation, a Delaware corporation, (the "Company"), and certain investors including the undersigned, have entered into a Common Stock Purchase Agreement dated as of the date hereof (the "Purchase Agreement"), providing for the purchase of __________ shares (the "Shares") of the Company's Common Stock, par value $0.001 ("Company Common Stock") and a warrant (the "Warrant") to purchase __________ shares of Company Common Stock (the "Warrant Shares") by the undersigned. The Shares, the Warrant and the Warrant Shares are collectively referred to herein as the "Securities."
andRights Agreement • July 23rd, 2001 • Geron Corporation • Pharmaceutical preparations • California
1 EXHIBIT 10.41Registration Rights Agreement • December 17th, 1998 • Geron Corporation • Pharmaceutical preparations • New York
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 240.24b-2 Agreement No. 99-0027 LICENSE AGREEMENT This Agreement is made effective the 23rd day of April, 1999, by and between...License Agreement • January 21st, 2000 • Geron Corporation • Pharmaceutical preparations
GERON CORPORATION AND _____________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF __________ GERON CORPORATION FORM OF PREFERRED STOCK WARRANT AGREEMENTPreferred Stock Warrant Agreement • January 4th, 2023 • Geron Corp • Pharmaceutical preparations • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between GERON CORPORATION, a Delaware corporation (the “Company ”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
Exhibit4.4 Amended and Restated Series D-2 Stock Purchase Warrant, dated as of May 23, 2003 ------------------------------------------------------------------ --------------Stock Purchase Warrant • May 27th, 2003 • Geron Corporation • Pharmaceutical preparations
EXHIBIT 4.2Warrant Agreement • December 17th, 1998 • Geron Corporation • Pharmaceutical preparations
RECITALSLease Amendment • March 1st, 2002 • Geron Corporation • Pharmaceutical preparations
EXHIBIT 4.2 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR...Warrant Agreement • October 30th, 2007 • Geron Corp • Pharmaceutical preparations • New York
AMENDMENT NO. 1 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 1st, 1999 • Geron Corporation • Pharmaceutical preparations • New York
GERON CORPORATION AND _____________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF __________Common Stock Warrant Agreement • September 4th, 2020 • Geron Corp • Pharmaceutical preparations • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “ Agreement ”), dated as of [●], between GERON CORPORATION , a Delaware corporation (the “ Company ”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “ Warrant Agent ”).
GERON CORPORATION AND _____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF __________Warrant Agreement • January 4th, 2023 • Geron Corp • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “ Agreement ”), dated as of [•], between GERON CORPORATION , a Delaware corporation (the “ Company ”) and [•], a [corporation] [national banking association]organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “ Warrant Agent ”).
Agreement No. 02-0273 LICENSE AGREEMENT This Agreement is made effective the 8th day of January, 2002, by and between Wisconsin Alumni Research Foundation (hereinafter called "WARF"), a nonstock, nonprofit Wisconsin corporation, and Geron Corporation...License Agreement • January 18th, 2002 • Geron Corporation • Pharmaceutical preparations
INDENTUREIndenture • January 29th, 2002 • Geron Corporation • Pharmaceutical preparations • New York
1 EXHIBIT 2.1Sale and Purchase Agreement • May 18th, 1999 • Geron Corporation • Pharmaceutical preparations
EXHIBIT 4.1 SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 6th, 2000 • Geron Corporation • Pharmaceutical preparations • Delaware
17,391,305 Shares of Common Stock par value $0.001 2,608,695 Over-Allotment Shares GERON CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2010 • Geron Corp • Pharmaceutical preparations • New York
EXHIBIT 4.1Registration Rights Agreement • May 18th, 1999 • Geron Corporation • Pharmaceutical preparations • Delaware
